Clinical use of dendritic cells for cancer therapy.

By S. Anguille, E. Smits, E. Lion, V. V. Van Tendeloo, Z. Berneman. The Lancet Oncology, 2014

631 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/014feb15f265e346a6459a52ee9028bb59f66fac

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. J. Joyce
2. D. Quail

In Oncology

1. J. Joyce
2. D. Quail
3. R. Weinberg

Citations in the corpus

• The microenvironmental landscape of brain tumors (2017, background): “…has largely taken a different tack; as interest for immune checkpoint inhibitors in cancer therapy continues to expand, DC vaccines are likewise gaining significant clinical attention as an alternative strategy to stimulate T cell responses (Anguille et al., 2014; Palucka and Banchereau, 2012).”